PMS2 and colorectal carcinoma: A prospective study examining the expression of PMS2 protein in 3213 cases of CRC and 215 cases of EC (primarily EEC) revealed that 7% of EC cases exhibited isolated loss of PMS2 expression, a rate significantly higher than the 0.04% observed in CRC.